Epithelial-Specific SHP1-P2 Methylation - a Novel Universal Tumor Marker for Detection of Colorectal Cancer Lymph Node Metastasis |
Rattanatanyong, Prakasit
(Center of Excellence in Molecular Genetics of Cancer and Human Disease, Department of Anatomy, Faculty of Medicine, Chulalongkorn University)
Keelawat, Somboon (Department of Pathology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital) Kitkumthorn, Nakarin (Department of Oral Biology, Faculty of Dentistry, Mahidol University) Mutirangura, Apiwat (Center of Excellence in Molecular Genetics of Cancer and Human Disease, Department of Anatomy, Faculty of Medicine, Chulalongkorn University) |
1 | Anglim PP, Alonzo TA, Laird-Offringa IA (2008). DNA methylation-based biomarkers for early detection of nonsmall cell lung cancer: an update. Mol Cancer, 7, 81. DOI |
2 | Kitkumthorn N, Keelawat S, Rattanatanyong P, et al (2012). LINE-1 and Alu methylation patterns in lymph node metastases of head and neck cancers. Asian Pac J Cancer Prev, 13, 4469-75. DOI |
3 | Patel A, Groopman JD, Umar A (2003). DNA methylation as a cancer-specific biomarker: from molecules to populations. Ann N Y Acad Sci, 983, 286-97. DOI |
4 | Patel V, Martin D, Malhotra R, et al (2013). DSG3 as a biomarker for the ultrasensitive detection of occult lymph node metastasis in oral cancer using nanostructured immunoarrays. Oral Oncol, 49, 93-101. DOI |
5 | Payne SR, Serth J, Schostak M, et al (2009). DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for noninvasive detection. Prostate, 69, 1257-69. DOI |
6 | Ruchusatsawat K, Wongpiyabovorn J, Shuangshoti S, et al (2006). SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis. J Mol Med (Berl), 84, 175-82. DOI |
7 | Safar AM, Spencer H, Su X, et al (2007). Promoter hypermethylation for molecular nodal staging in non-small cell lung cancer. Arch Pathol Lab Med, 131, 936-41. |
8 | Vinayanuwattikun C, Chantranuwat P, Sriuranpong V, et al (2014).The role of SHP-1 promoter 2 hypermethylation detection of lymph node micrometastasis in resectable stage I non-small cell lung cancer as a prognostic marker of disease recurrence. Int J Clin Oncol, 19, 586-92. DOI |
9 | Vinayanuwattikun C, Sriuranpong V, Tanasanvimon S, et al (2011). Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer. J Thorac Oncol, 6, 1818-25. DOI |
10 | Vinayanuwattikun C, Winayanuwattikun P, Chantranuwat P, et al (2013). The impact of non-tumor-derived circulating nucleic acids implicates the prognosis of non-small cell lung cancer. J Cancer Res Clin Oncol, 139, 67-76. DOI |
11 | Kim MS, Lee J, Sidransky D (2010). DNA methylation markers in colorectal cancer. Cancer Metastasis Rev, 29, 181-206. DOI |
12 | Brock MV, Hooker CM, Ota-Machida E, et al (2008). DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med, 358, 1118-28. DOI |
13 | Chujan S, Kitkumthorn N, Siriangkul S, et al (2014). CCNA1 promoter methylation: a potential marker for grading Papanicolaou smear cervical squamous intraepithelial lesions. Asian Pac J Cancer Prev, 15, 7971-5. DOI |
14 | Huynh KT, Hoon DS (2012). Epigenetics of regional lymph node metastasis in solid tumors. Clin Exp Metastasis, 29, 747-56. DOI |
15 | Toyooka S, Toyooka KO, Maruyama R, et al (2001). DNA methylation profiles of lung tumors. Mol Cancer Ther, 1, 61-7. |
16 | Tiwawech D, Srisuttee R, Rattanatanyong P, et al (2014). Alu methylation in serum from patients with nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 15, 9797-800. DOI |